Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y1GJ
|
||||
Former ID |
DIB012646
|
||||
Drug Name |
MLN-576
|
||||
Synonyms |
XR-11576
|
||||
Indication | Acute lymphoblastic leukemia [ICD9: 204.0, 556; ICD10:C91.0] | Phase 1 | [526301] | ||
Company |
Xenova Group plc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
n1c2c(C(=O)N[C@@H](CN(C)C)C)cccc2nc2c1c1c(cc2)c(OC)ccc1
|
||||
CAS Number |
CAS 346689-77-8
|
||||
Target and Pathway | |||||
Target(s) | Toposisomerase-1 | Target Info | Modulator | [526301] | |
DNA topoisomerase II | Target Info | Modulator | [526301] | ||
NetPath Pathway | IL2 Signaling Pathway | ||||
PANTHER Pathway | DNA replication | ||||
Pathway Interaction Database | Caspase Cascade in Apoptosis | ||||
WikiPathways | Integrated Pancreatic Cancer Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.